Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B - PubMed

Affiliations

• PMID: 29948332
• DOI: 10.1007/s00438-018-1460-3

Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B

Rencia van der Sluis. Mol Genet Genomics. 2018 Oct.

Abstract

Benzoate (found in milk and widely used as preservative), salicylate (present in fruits and the active component of aspirin), dietary polyphenols produced by gut microbiota, metabolites from organic acidemias, and medium-chain fatty acids (MCFAs) are all metabolised/detoxified by the glycine conjugation pathway. Xenobiotics are first activated to an acyl-CoA by the mitochondrial xenobiotic/medium-chain fatty acid: CoA ligases (ACSMs) and subsequently conjugated to glycine by glycine N-acyltransferase (GLYAT). The MCFAs are activated to acyl-CoA by the ACSMs before entering mitochondrial β-oxidation. This two-step enzymatic pathway has, however, not been thoroughly investigated and the biggest gap in the literature remains the fact that studies continuously characterise the pathway as a one-step reaction. There are no studies available on the interaction/competition of the various substrates involved in the pathway, whilst very little research has been done on the ACSM ligases. To identify variants/haplotypes that should be characterised in future detoxification association studies, this study assessed the naturally observed sequence diversity and protein expression variation of ACSM2A and ACSM2B. The allelic variation, haplotype diversity, Tajima's D values, and phylogenetic analyses indicated that ACSM2A and ACSM2B are highly conserved. This confirmed an earlier hypothesis that the glycine conjugation pathway is highly conserved and essential for life as it maintains the CoA and glycine homeostasis in the liver mitochondria. The protein expression analyses showed that ACSM2A is the predominant transcript in liver. Future studies should investigate the effect of the variants identified in this study on the substrate specificity of these proteins.

Keywords: ACSM2A; ACSM2B; Benzoate; Glycine conjugation; Medium-chain fatty acids; Salicylate; Xenobiotic/medium-chain fatty acid: CoA ligases.

Similar articles

• Xenobiotic/medium chain fatty acid: CoA ligase - a critical review on its role in fatty acid metabolism and the detoxification of benzoic acid and aspirin.

  van der Sluis R, Erasmus E. van der Sluis R, et al. Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1169-79. doi: 10.1080/17425255.2016.1206888. Epub 2016 Jul 15. Expert Opin Drug Metab Toxicol. 2016. PMID: 27351777 Review.

• Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA.

  Rohwer JM, Schutte C, van der Sluis R. Rohwer JM, et al. Int J Mol Sci. 2021 Mar 18;22(6):3129. doi: 10.3390/ijms22063129. Int J Mol Sci. 2021. PMID: 33803916 Free PMC article.

• Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids.

  Knights KM. Knights KM. Clin Exp Pharmacol Physiol. 1998 Oct;25(10):776-82. doi: 10.1111/j.1440-1681.1998.tb02152.x. Clin Exp Pharmacol Physiol. 1998. PMID: 9784915 Review.

• Isolation from bovine liver mitochondria and characterization of three distinct carboxylic acid: CoA ligases with activity toward xenobiotics.

  Vessey DA, Hu J. Vessey DA, et al. J Biochem Toxicol. 1995 Dec;10(6):329-37. doi: 10.1002/jbt.2570100608. J Biochem Toxicol. 1995. PMID: 8934636

• Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids.

  Vessey DA, Kelley M, Warren RS. Vessey DA, et al. Biochim Biophys Acta. 1999 Aug 5;1428(2-3):455-62. doi: 10.1016/s0304-4165(99)00088-4. Biochim Biophys Acta. 1999. PMID: 10434065

Cited by

• Hepatic Transcriptome Profiling Reveals Lack of Acsm3 Expression in Polydactylous Rats with High-Fat Diet-Induced Hypertriglyceridemia and Visceral Fat Accumulation.

  Junková K, Mirchi LF, Chylíková B, Janků M, Šilhavý J, Hüttl M, Marková I, Miklánková D, Včelák J, Malínská H, Pravenec M, Šeda O, Liška F. Junková K, et al. Nutrients. 2021 Apr 25;13(5):1462. doi: 10.3390/nu13051462. Nutrients. 2021. PMID: 33923085 Free PMC article.

• Drug-Initiated Activity Metabolomics Identifies Myristoylglycine as a Potent Endogenous Metabolite for Human Brown Fat Differentiation.

  Guijas C, To A, Montenegro-Burke JR, Domingo-Almenara X, Alipio-Gloria Z, Kok BP, Saez E, Alvarez NH, Johnson KA, Siuzdak G. Guijas C, et al. Metabolites. 2022 Aug 16;12(8):749. doi: 10.3390/metabo12080749. Metabolites. 2022. PMID: 36005620 Free PMC article.

• Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease.

  Jiang H, Chen C, Gao J. Jiang H, et al. Nutrients. 2022 Dec 28;15(1):151. doi: 10.3390/nu15010151. Nutrients. 2022. PMID: 36615808 Free PMC article. Review.

• Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity.

  Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM. Menni C, et al. Gut Microbes. 2019;10(6):688-695. doi: 10.1080/19490976.2019.1586038. Epub 2019 Apr 29. Gut Microbes. 2019. PMID: 31030641 Free PMC article.

• Expression of Acsm2, a kidney-specific gene, parallels the function and maturation of proximal tubular cells.

  Watanabe H, Paxton RL, Tolerico MR, Nagalakshmi VK, Tanaka S, Okusa MD, Goto S, Narita I, Watanabe S, Sequeira-Lοpez MLS, Gomez RA. Watanabe H, et al. Am J Physiol Renal Physiol. 2020 Oct 1;319(4):F603-F611. doi: 10.1152/ajprenal.00348.2020. Epub 2020 Aug 24. Am J Physiol Renal Physiol. 2020. PMID: 32830538 Free PMC article.

References

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal